CytoSorbents Corporation (CTSO)

[andy55q]

Successful Treatment of Severe Lamotrigine Intoxication with CytoSorb Hemoadsorption
Caterina Reuchsel et al. Blood Purif. 2021.
Hide details

Blood Purif
. 2021 Nov 4;1-4.
doi: 10.1159/000519167. Online ahead of print.
Authors

Caterina Reuchsel 1 , Falk Alexander Gonnert 1
Affiliation

1 Department of Anesthesiology and Intensive Care Medicine, SRH Klinikum Gera, Gera, Germany.
PMID: 34736249
DOI: 10.1159/000519167
Cite

Abstract

Severe intoxication with the anti-epileptic drug, lamotrigine can cause cardiovascular collapse, neurotoxicity - expressed as intractable seizures, and even death. As there is currently no known specific antidote, extracorporeal removal therapies such as CytoSorb hemoadsorption might represent a promising therapeutic option. We report on a deeply comatosed 60-year-old woman who was treated in our intensive care unit with severe lamotrigine intoxication. To support removal from the blood, combined treatment with continuous veno-venous hemodialysis and CytoSorb hemoadsorption was started. Pre- and post-adsorber drug level measurements showed the rapid elimination of lamotrigine accompanied by an impressive clinical improvement in the patient. Two days after treatment discontinuation, there were no more clinical signs of intoxication and the patient could be extubated, followed by transfer to the stroke unit in a stable condition the following day. In the absence of a viable antidote, for the efficient short-term removal of lamotrigine, hemoadsorption with the CytoSorb device could represent a feasible treatment option for patients with severe lamotrigine intoxication.